Search results
Jun 12, 2024 · Glenmark is a leading, research–based global pharmaceutical company. KNOW MORE. Glenmark Pharma is discovering advance therapies for a new world. We are creating centers of excellence in dermatology, oncology and...
The company focused on new drugs [9] and biosimilars in the fields of cancer, dermatology and respiratory diseases, which it sought to monetize by partnering with major pharmaceutical companies. [8] [10] In 2016 it had four such drugs in clinical trials. [11]
Glenmark Pharmaceuticals Limited is a research‐led, global pharmaceutical company, having a presence across branded, generics, and OTC segments; with a focus in the therapy areas of Respiratory, Dermatology and Oncology.
Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate...
2 days ago · Glenmark Pharmaceuticals Ltd has a significant presence in the branded generics markets across emerging economies including India.The company entered into the dermatology market through the...
2 days ago · Glenmark Pharmaceuticals Limited Stock Price Today, Live NSE Share Price: Get the latest Glenmark Pharmaceuticals Limited news, company updates, quotes, tips, historical charts, 52 week high low, market performance financial reports and many more at NSE India.
Get the latest Glenmark Pharmaceuticals Ltd (GLENMARK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment...
Glenmark Pharmaceuticals Ltd is a global research-led pharmaceutical company with presence across generics, Specialty and OTC business with operations in over 80 countries.
Jun 7, 2024 · Shares of Torrent Pharma and Glenmark Pharma surged post Q4 results. Torrent Pharma's net profit jumped 56% YoY while Glenmark Pharma reported increased losses. Motilal Oswal provides target prices for both companies.
Glenmark Pharmaceuticals Ltd. Share Price Today: CLOSE 1230, HIGH 1239.2, LOW: 1199.95. Get latest balance sheet, annual reports, quarterly results, and price chart.
